BRIT J CLIN PHARMACO 2020 10.1111/bcp.14339
Effects of various genetic polymorphisms on thiopurine treatment-associated outcomes for Korean patients with Crohn's disease
Choi1, R; Lee, MN; Kim, K; Baek, SY; Kim, TJ; Hong, SN; Kim, YH; Lee, SY

BMC ANESTHESIOL 2020 10.1186/s12871-020-01025-7
Intraoperative dexmedetomidine attenuates norepinephrine levels in patients undergoing transsphenoidal surgery: a randomized, placebo-controlled trial
Kang1, RA; Jeong, JS; Ko, JS; Lee, SY; Lee, JH; Choi, SJ; Cha, SR; Lee, JJ

ANN LAB MED 2020 10.3343/alm.2020.40.3.216
Development and Validation of a Novel Warfarin Dosing Algorithm for Korean Patients With VKORC1 1173C
Cho1, EH; Lee, K; Yang, M; Choi, R; Baek, SY; Sohn, I; Kim, JS; On, YK; Bang, OY; Cho, HJ; Lee, SY

J CHEMOTHERAPY 2020 10.1080/1120009X.2020.1755590
Weight-based vancomycin loading strategy may not improve achievement of optimal vancomycin concentration in patients with preserved renal function
Kim1, SH; Kang, CI; Lee, SH; Choi, JS; Huh, K; Cho, SY; Chung, DR; Park, HJ; Lee, SY; Kim, YJ; Peck, KR

MYCOSES 2020 10.1111/myc.13020
Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level
Oh1, J; Kang, CI; Kim, SH; Huh, K; Cho, SY; Chung, DR; Lee, SY; Jung, CW; Peck, KR

EUR J CLIN MICROBIOL 2019 10.1007/s10096-019-03652-6
Evaluating the optimal dose of teicoplanin with therapeutic drug monitoring: not too high for adverse event, not too low for treatment efficacy
Kim1, SH; Kang, CI; Huh, K; Cho, SY; Chung, DR; Lee, SY; Kim, YJ; Peck, KR

ANN LAB MED 2019 10.3343/alm.2019.39.5.447
Use of Liquid Chromatography-Tandem Mass Spectrometry for Clinical Testing in Korean Laboratories: a Questionnaire Survey
Chae1, H; Cho, SE; Park, HD; Chun, S; Lee, YW; Yun, YM; Song, SH; Lee, SG; Lee, K; Song, J; Lee, SY

CLIN BIOCHEM 2019 10.1016/j.clinbiochem.2019.06.003
Experience with therapeutic drug monitoring of three antifungal agents using an LC-MS/MS method in routine clinical practice
Yoon1, SJ; Lee, K; Oh, J; Woo, HI; Lee, SY

BRIT J CLIN PHARMACO 2019 10.1111/bcp.13943
Pathway genes and metabolites in thiopurine therapy in Korean children with acute lymphoblastic leukaemia
Choi1, R; Sohn, I; Kim, MJ; Woo, HI; Lee, JW; Ma, Y; Yi, ES; Koo, HH; Lee, SY

INFECT DRUG RESIST 2019 10.2147/IDR.S208783
A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea
Choi1, R; Woo, HI; Park, HD; Lee, SY

J TRACE ELEM MED BIO 2019 10.1016/j.jtemb.2019.02.004
Assessment of 7 trace elements in serum of patients with nontuberculous mycobacterial lung disease
Oh1, J; Shin, SH; Choi, R; Kim, S; Park, HD; Kim, SY; Han, SA; Koh, WJ; Lee, SY

J PHARMACEUT BIOMED 2019 10.1016/j.jpba.2019.02.001
Therapeutic drug monitoring of teicoplanin using an LC-MS/MS method: Analysis of 421 measurements in a naturalistic clinical setting
Jung1, J; Lee, K; Oh, J; Choi, R; Woo, HI; Park, HD; Kang, CI; Kim, YJ; Lee, SY

ANN LAB MED 2019 10.3343/alm.2020.40.2.95
Therapeutic Drug Monitoring of Biologic Agents in the Era of Precision Medicine
Lee1, SY

NUTRIENTS 2019 10.3390/nu11030668
Reply: "Letter to the Editor Re: Oh J., et al. Nutrients 2019, 11, 343"
Oh1, J; Park, HD; Kim, SY; Koh, WJ; Lee, SY

ANN LAB MED 2019 10.3343/alm.2019.39.3.269
Dried Blood Spot Multiplexed Steroid Profiling Using Liquid Chromatography Tandem Mass Spectrometry in Korean Neonates
Choi1, R; Park, HD; Oh, HJ; Lee, K; Song, J; Lee, SY
외 다수